Oramed Pharmaceuticals: Hold On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction
…
3,435€
-5,04%
Echtzeit-Aktienkurs Oramed Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Oramed Pharmaceuticals Inc. Aktie
ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value
By M. MarinNASDAQ:ORMPREAD THE FULL ORMP RESEARCH REPORTTransaction enables exposure to both oral drug delivery program & medical device businessesOramed…
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback
…
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted
By M. MarinNASDAQ:ORMPREAD THE FULL ORMP RESEARCH REPORTADVANCING ORMD-0801 THROUGH CLINICAL STUDIESTrial will focus on key patient subpopulations that have…
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an…
Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies
PALO ALTO, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”),…